ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in ESSA Pharma Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +2 vs. Q1 2023
- Shares held
- 33.2M
- +157.3K (+0.5%) vs. Q1 2023
- Total value
- $89.8M
- −$8.50M (−8.7%) vs. Q1 2023
- New holders
- 5
- 6 more added
- Sold out
- 3
- 10 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 48 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8 | $22 | 0.00% | −2,162−99.6% | Reduced |
| Tower Research Capital LLC (TRC) | 27 | $73 | 0.00% | +27 | New |
| Newbridge Financial Services Group, Inc. | 31 | $84 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 50 | $135 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 430 | $1.16K | 0.00% | −2,824−86.8% | Reduced |
| Laurel Wealth Advisors LLC | 600 | $1.62K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 775 | $2.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 900 | $2.41K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,261 | $6.11K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 5,225 | $14.1K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 5,689 | $15.0K | 0.00% | +5,689 | New |
| Hunting Hill Global Capital, LLC | 10,000 | $27.0K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,883 | $29.4K | 0.00% | +10,883 | New |
| Northern Trust Corp | 12,489 | $33.7K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 14,405 | $38.9K | 0.00% | +4,976+52.8% | Added |
| Acadian Asset Management LLC | 15,903 | $42.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 19,039 | $51.4K | 0.00% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 20,032 | $55.3K | 0.04% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 21,946 | $59.3K | 0.00% | −27,316−55.5% | Reduced |
| State Street Corp | 24,414 | $65.9K | 0.00% | −438−1.8% | Reduced |
| Driehaus Capital Management LLC | 28,300 | $76.4K | 0.00% | −236,271−89.3% | Reduced |
| Group One Trading, L.P. | 31,264 | $84.4K | 0.00% | +31,264 | New |
| JPMorgan Chase & Co | 43,873 | $118.5K | 0.00% | −15,833−26.5% | Reduced |
| Susquehanna International Group, LLP | 49,530 | $133.7K | 0.00% | +49,530 | New |
| Two Sigma Advisers, LP | 82,300 | $222.2K | 0.00% | −141,500−63.2% | Reduced |
| Connective Capital Management, LLC | 142,727 | $385.4K | 0.45% | 00.0% | Unchanged |
| CIBC World Markets Inc. | 160,643 | $434.0K | 0.00% | −48,148−23.1% | Reduced |
| D. E. Shaw & Co., Inc. | 168,050 | $453.7K | 0.00% | −4,171−2.4% | Reduced |
| Rhenman & Partners Asset Management AB | 356,500 | $962.5K | 0.10% | 00.0% | Unchanged |
| Millennium Management LLC | 469,002 | $1.27M | 0.00% | +49,935+11.9% | Added |
| Rock Springs Capital Management LP | 663,317 | $1.79M | 0.04% | +138,373+26.4% | Added |
| OrbiMed Advisors LLC | 921,940 | $2.49M | 0.05% | −276,397−23.1% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,042,531 | $2.81M | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 3,870,080 | $10.4M | 0.00% | +764,865+24.6% | Added |
| Soleus Capital Management, L.P. | 4,202,094 | $11.3M | 1.26% | +56,977+1.4% | Added |
| PFM Health Sciences, LP | 4,204,953 | $11.4M | 0.46% | +43,492+1.0% | Added |
| Bellevue Group AG | 7,898,583 | $21.3M | 0.30% | 00.0% | Unchanged |
| BVF Inc | 8,748,629 | $23.6M | 0.66% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −236,583−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −6,852−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −265−100.0% | Sold out |